Gupta A, Norton I. ‘Patient preparation and Principles of Sedation for Gastrointestinal Endoscopy’ in Clinical Gastroenterology: a practical problem-based approach / Nicholas Talley (ed). 3rd Edition (2011) Link
Gupta A, Kang S, Wagner J, Kirkwood C, Morrison M, et al. Analysis of Mucosal Microbiota in Inflammatory Bowel Disease using a Custom Phylogenetic Microarray. Austin J Gastroenterol. 2014;1(4): 6. Link
Gupta A, Macrae FA, Gibson PR. Vaccination And Screening For Infections In Patients With Inflammatory Bowel Disease: A Survey Of Australian Gastroenterologists. Intern Med J. 2011 Jun; 41(6):462-7. Link
Sheffield LJ, Irving P, Gupta A, Byron K, Macrae FA, Phillimore H, et al. Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs. Pharmacogenomics 2009;10(7):1091-9. Link pdf
Understanding the role of infections in the pathogenesis of inflammatory bowel disease, and improving the quality and safety of treatment. Minerva, University of Melbourne 2015. Link
Huang W, Turbayne A, Diwaker H, Gupta A. Extra-luminal findings are common in a cohort of hospital clinic patients undergoing outpatient computed tomography colonography. Australian Gastroenterology Week 2019
Turbayne A, Gupta A. Use of CT Colonography as an Alternative to Colonoscopy for Investigating Patients with Comorbidities or Advanced Age in a Public Hospital Gastroenterology Clinic. Australian Gastroenterology Week 2018
Sivanes S, Davenport A, Gupta A. Responses to Salvage Therapy for Loss of Response to Infliximab in Patients with IBD Do Not Vary Between Type 1 and Type 2 Loss of Response. Australian Gastroenterology Week 2017.
O McKay, S Wood, L Ottaway, D Velasco, R Carsula, A Gupta. Serrated lesion detection based quality markers in colonoscopy: ready for prime time? Digestive Diseases Week Chicago 2017, Canberra Hospital Annual Research Meeting (CHARM) August 2017, Australian Gastroenterology Week 2016.
Sivanes S, Davenport A, Gupta A. Loss of response to infliximab is common amongst patients with inflammatory bowel disease and varies according to definition. Canberra Hospital Annual Research Meeting (CHARM) August 2017, Australian Gastroenterology Week 2016.
Gupta A. Withdrawal of anti-TNF therapy and use of combination therapy in inflammatory bowel disease varies significantly in Australia. Australian Gastroenterology Week 2016.
Gupta A, Kang S, Wagner J, Morrison M, Macrae F, McSweeney C. Analysis of the mucosal microbiota from inflammatory bowel disease biopsy tissues using a custom 16s rRNA based phylogenetic microarray. Digestive Diseases Week 2010, Australian Gastroenterology Week 2009
La Nauze R, Gupta A, Brown G. Audit of Single Balloon versus Double Balloon Enteroscopy For A Single Operator. Australian Gastroenterology Week 2009